SE

Olink announces change of date for Annual General Meeting

Retrieved on: 
Friday, March 8, 2024

UPPSALA, Sweden, March 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Olink’s 2024 Annual General Meeting (“AGM”) will be held in Uppsala, Sweden on April 19th, 2024. The AGM was previously scheduled to take place on April 17th, 2024.

Key Points: 

UPPSALA, Sweden, March 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Olink’s 2024 Annual General Meeting (“AGM”) will be held in Uppsala, Sweden on April 19th, 2024. The AGM was previously scheduled to take place on April 17th, 2024.

Oatly Continues North American Beverage Portfolio Expansion with the Launch of Flavored Oatmilk Creamers

Retrieved on: 
Tuesday, February 27, 2024

MALMÖ, Sweden, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and largest oatmilk company, today announced the launch of Oatly Oatmilk Creamers in the US, a new beverage innovation that joins the brand’s growing fluid portfolio aimed at inspiring increased use in coffee occasions.

Key Points: 
  • MALMÖ, Sweden, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and largest oatmilk company, today announced the launch of Oatly Oatmilk Creamers in the US, a new beverage innovation that joins the brand’s growing fluid portfolio aimed at inspiring increased use in coffee occasions.
  • With plant-based creamers up 13% in dollar sales and 9% in unit sales, respectively, in the last 52 weeks1, Oatly believes this initial move into flavored creamers will unlock a strong opportunity to reach new and existing buyers.
  • Shoppers can expect to find Oatly Creamers in the refrigerated aisle of retailers nationwide, including Walmart, Target, Albertsons, Kroger, Stop & Shop, and more, with a suggested retail price of $5.99.
  • “As a company, we’re committed to converting cow’s milk drinkers into oatmilk buyers, so we’re excited to now offer fantastic, flavored creamers to people looking for a sweeter, more indulgent coffee experience.

Anocca Appoints Martin Welschof to Board of Directors

Retrieved on: 
Tuesday, February 13, 2024

SÖDERTÄLJE, Sweden, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Anocca AB, a leading TCR-T1 cell therapy company, today announced the appointment of Martin Welschof to its Board of Directors.

Key Points: 
  • SÖDERTÄLJE, Sweden, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Anocca AB, a leading TCR-T1 cell therapy company, today announced the appointment of Martin Welschof to its Board of Directors.
  • Martin Welschof is currently CEO of BioInvent International AB, a listed clinical-stage cancer immunotherapy company.
  • He brings relevant biotech experience having launched and built successful businesses focused on drug development and drug discovery platforms,” said Hans Stråberg, Chairman of the board, Anocca.
  • The company has made impressive progress since its inception, and I look forward to working with the team as it pushes forward into the clinic,” said Martin Welschof, Anocca’s newly appointed board member.

AnaMar Announces US and EU Orphan Drug Designation for AM1476 for Treating Systemic Sclerosis

Retrieved on: 
Monday, February 5, 2024

AM1476 offers a unique dual-action approach to treat both skin and lung manifestations of systemic sclerosis.

Key Points: 
  • AM1476 offers a unique dual-action approach to treat both skin and lung manifestations of systemic sclerosis.
  • Systemic sclerosis is a chronic, progressive, autoimmune disease characterized by inflammation and fibrosis, i.e.
  • AnaMar's Chief Executive Officer, Dr. Ulf Ljungberg, said: “We are delighted with the FDA’s and EMA’s decisions to grant orphan drug designation to AM1476 for SSc.
  • Orphan drug designation provides certain benefits, including the potential for extensive marketing exclusivity following regulatory approval, reduction in regulatory fees and, in the case of EU, a centralized approval process.

Oatly Announces Sweet Collaboration with Carvel®, One of America’s Most Beloved Ice Cream Destinations

Retrieved on: 
Monday, January 22, 2024

With its innovative approach to creating oat-based products, Oatly is able to deliver a delightful range of premium, non-dairy frozen desserts that don’t compromise on great taste or texture.

Key Points: 
  • With its innovative approach to creating oat-based products, Oatly is able to deliver a delightful range of premium, non-dairy frozen desserts that don’t compromise on great taste or texture.
  • “Carvel's iconic presence and longstanding success in the industry serve as a testament to its commitment to quality,” said Drew Martin, EVP Commercial Sales, Oatly North America.
  • “With ice cream traditionally being reliant on cow’s dairy, we’re honored to collaborate with Carvel and present the first oatmilk-based, non-dairy frozen desserts available in Carvel shoppes.
  • “We are thrilled to bring Oatly products to Carvel,” said Jim Salerno, Chief Brand Officer at Carvel.

Oatly to Report Fourth Quarter 2023 Financial Results on February 15, 2024

Retrieved on: 
Tuesday, January 16, 2024

MALMÖ, Sweden, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY), the world’s original and largest oat drink company, will report financial results for the fourth quarter ended December 31, 2023, on Thursday, February 15, 2024, before the U.S. market opens.

Key Points: 
  • MALMÖ, Sweden, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY), the world’s original and largest oat drink company, will report financial results for the fourth quarter ended December 31, 2023, on Thursday, February 15, 2024, before the U.S. market opens.
  • Oatly will host a conference call and webcast at 8:30 a.m.
  • ET on the same day to discuss the results.
  • The conference call and simultaneous live webcast can be accessed on Oatly’s Investors website at https://investors.oatly.com under “Events.” The webcast will be archived for 30 days.

Oatly Launches Two New Oatmilk Varieties, Marking the Company’s First Major Innovations to its Core North American Beverage Portfolio in Five Years

Retrieved on: 
Monday, January 8, 2024

Both products are formulated to check different nutritional boxes while still delivering the same delicious Oatly taste consumers know and love.

Key Points: 
  • Both products are formulated to check different nutritional boxes while still delivering the same delicious Oatly taste consumers know and love.
  • Oatly Unsweetened Oatmilk features a brand-new proprietary oat base specially developed by the Company to deliver 0g of sugar.
  • Oatly Unsweetened is a delightfully light and smooth beverage at just 40 calories per serving.
  • Oatly Super Basic boasts all the creamy, deliciousness oatmilk can offer with a simpler formulation.

Anocca Secures GMP Manufacturing License To Push Novel KRAS TCR-T Cell Therapies Into Clinical Development

Retrieved on: 
Thursday, January 4, 2024

The manufacturing license paves the way for Anocca’s near-term path to the clinic and long-term strategy to advance franchises2 of precision targeted cell therapies for different cancers and covering diverse patient populations.

Key Points: 
  • The manufacturing license paves the way for Anocca’s near-term path to the clinic and long-term strategy to advance franchises2 of precision targeted cell therapies for different cancers and covering diverse patient populations.
  • Anocca has built validated asset franchises against valuable cancer targets including KRAS, PRAME and MAGE, with more than 40 preclinical assets in the pipeline.
  • Anocca will initiate its first clinical program in hard-to-treat solid tumour indications with TCR-T therapies across multiple KRAS mutation forms and patient segments.
  • 1 TCR-T therapies: T cell receptor-engineered T cell therapies – a type of cell therapy that uses the natural targeting ability of T cells to identify and eradicate diseased cells like cancer.

Oatly Announces Nationwide Availability at The Coffee Bean & Tea Leaf®

Retrieved on: 
Wednesday, January 3, 2024

MALMÖ, Sweden, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and largest oat drink company, today announced a new foodservice distribution arrangement with The Coffee Bean & Tea Leaf® Brand, one of the world’s leading roasters and retailers of specialty coffee and tea.

Key Points: 
  • MALMÖ, Sweden, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY)(“Oatly” or the “Company”), the world’s original and largest oat drink company, today announced a new foodservice distribution arrangement with The Coffee Bean & Tea Leaf® Brand, one of the world’s leading roasters and retailers of specialty coffee and tea.
  • Available at more than 180 cafes throughout the US, Oatly Barista Edition is now offered as the exclusive oatmilk in-stores, bringing a creamy, milk alternative to coffee and tea aficionados.
  • "We're thrilled to bring Oatly to customers of The Coffee Bean & Tea Leaf®, an iconic brand that cherishes a great coffee experience just like we do," said Mike Messersmith, President, Oatly North America.
  • To find a location of The Coffee Bean & Tea Leaf® near you, visit CoffeeBean.com.